Search

Your search keyword '"Schoemaker, Minouk J."' showing total 829 results

Search Constraints

Start Over You searched for: Author "Schoemaker, Minouk J." Remove constraint Author: "Schoemaker, Minouk J."
829 results on '"Schoemaker, Minouk J."'

Search Results

51. Supplementary Table 5 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

52. Table S1 from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

53. Supplementary Data from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

54. Data from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

55. Supplementary Figures from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

56. Data from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

57. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

59. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

60. Two truncating variants in FANCC and breast cancer risk

61. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma

62. Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk

63. Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model

64. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

66. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

67. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

71. Impact of atopy on risk of glioma: a Mendelian randomisation study

72. Association analysis identifies 65 new breast cancer risk loci

73. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

74. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

75. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

76. Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

78. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

79. Additional file 4 of Common variants in breast cancer risk loci predispose to distinct tumor subtypes

82. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

83. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

86. Correction:Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom (British Journal of Cancer, (2021), 124, 12, (2026-2034), 10.1038/s41416-021-01278-0)

87. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

88. Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

92. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

93. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

94. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

95. Gestational diabetes and risk of breast cancer before age 55 years

96. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

97. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

98. Genetic insights into biological mechanisms governing human ovarian ageing

99. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

100. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

Catalog

Books, media, physical & digital resources